Skip to main content

Yale scientists edit genetic diseases out of mice before birth; humans are next

Gene-editing techniques such as CRISPR/Cas9 can be used to astonishing, potential life-altering effect, such as one demonstration involving a possible treatment for ALS. Researchers at Carnegie Mellon University and Yale University have now made a significant breakthrough in the technology’s usefulness — by demonstrating how gene editing can be used to treat genetic conditions during fetal development.

While so far it has only been showcased in an experiment with mice, in the future it could help treat the millions of children who are born each year with severe genetic disorders or birth defects. At present, some of these genetic conditions can be detected during pregnancy, although they cannot be corrected during fetal development.

Recommended Videos

“This is the first description of a genetic disease corrected by gene editing delivered to a developing mammalian fetus,” David Stitelman, assistant professor of surgery at Yale School of Medicine, told Digital Trends. “The gene editing reagents are in the form of peptide nucleic acids called PNA, which bind chromosomal DNA in a specific manner. The PNAs are designed to bind just upstream or downstream to a disease-causing mutation. The cell’s own editing machinery detects where the PNA has bound the chromosome and removes that segment.”

In their study, the researchers used the technique to correct 6 percent of the mutations in the gene causing beta thalassemia, a blood disorder that reduces the production of hemoglobin. Just one injection of the PNA complex into the amniotic fluid of pregnant mice caused dramatic improvements in their affected offspring. These improvements were significant enough that the mice were functionally cured of the disease.

“This work can be translated in human patients clinically,” Stitelman continued. “This approach could be used for most diseases where a known genetic mutation causes the disease. Many of these diseases are devastating and currently without cure. Our approach corrects the disease at the most fundamental level and in the most rational way. At this point, there are about 6,000 diseases that fit that description that impact about one in 200 babies.”

Possible diseases the work could help treat include neurologic diseases like Tay Sachs disease or spinal muscular atrophy, blood diseases such as sickle cell anemia, thalassemia and hemophilia, muscle diseases like muscular dystrophy, and diseases of the airway and intestinal tract including cystic fibrosis.

“We are [now] using this technology in other mouse models of human genetic disease,” Stitelman said. “We are continually optimizing the PNA/DNA editing reagents and the nanoparticles that encapsulate those agents. For future translation, we need to determine safety and efficacy in larger animals before applying this technology clinically.”

A paper describing the work was recently published in Nature Communications.

Luke Dormehl
Former Digital Trends Contributor
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Waymo’s Hyundai robotaxi deal may steal the show from Tesla
A Hyundai Ioniq 5 is equipped as a robotaxi.

Just days ahead of Tesla’s much anticipated robotaxi event on Thursday, Hyundai unveiled a partnership with Waymo that will add Hyundai’s Ioniq 5 to the fleet of the robotaxi operator.In the first phase of the partnership, Waymo will integrate its sixth-generation fully autonomous technology, called the Waymo Driver, into the all-electric Ioniq 5 SUV, which will be added to the Waymo One fleet over time.On-road testing with Waymo-enabled Ioniq 5s is due to start in late 2025 and become available to riders of the Waymo One robotaxi service the following year.Alphabet-owned Waymo currently operates the only functioning robotaxi service in the U.S., with a fleet of about 700 self-driving vehicles already on the road in Phoenix, Los Angeles and San Francisco. The service is also being tested in Austin, Texas.Last year, General Motors’ competing robotaxi service Cruise had to stop operations after one of its vehicles struck a pedestrian in San Francisco. Cruise’s GM vehicles are nonetheless expected to resume operations next year through a partnership with Uber.Driverless vehicles have stumbled on two main obstacles on the road to commercialization: The complexity of the technology and tight safety regulations.For now, Waymo’s existing footprint gives it a marked advantage over its competitors. Its sixth-generation technology is said to handle a wider array of weather conditions with fewer on-board cameras and sensors. In their joint statement, Waymo and Hyundai emphasized the proven safety of both the Waymo technology and the Ioniq 5. Waymo’s technology relies on pre-mapped roads, sensors, cameras, radar and lidar (a laser-light radar). It's an approach that might be very costly but has met the approval of safety regulators. All this adds pressure on Tesla to deliver the goods with the launch of its robotaxi -- expected to be called the Cybercab.Tesla’s ambition has been to eventually provide full driverless capacity directly to consumers. Tesla owners can already buy software called Full Self-Driving (FSD) that operates like an advanced driver assistance system and requires constant driver supervision.Tesla’s FSD relies on multiple onboard cameras to feed machine-learning models that, in turn, help the car make decisions based on what it sees.The technology, however, has not yet convinced all current and former traffic safety officials.

Read more
Tesla reveals price range for Optimus Gen2, its ‘robot without wheels’
Tesla's 2022 Optimus robot prototype is seen in front of the company logo.

“The future should look like the future”, CEO Elon Musk said at the Tesla "We Robot" special event held in Burbank, California, earlier this week. Sure enough, Tesla’s much-anticipated autonomous robotaxi, the Cybercab, and its large-van counterpart, the Cybervan, seemed straight out of celebrated sci-fi movies. But as the name of the event hinted at, a vision of the future would not be complete without robots: Several of the Optimus Gen 2, Tesla’s latest version of humanoid-like robot, were found serving drinks, holding conversations with guests, and even dancing at the event.Tesla has recently pitched the Optimus as a potential replacement for factory workers in China and elsewhere. Musk previously said he expects the Optimus to start working at Tesla factories in 2025 and to be available to other firms in 2026.
Yet, at the event, the Tesla boss revealed his expanded vision of a household robot that can do “everything you want: Babysit your kid, walk your dog, mow your lawn, get the groceries, just be your friend, serve drinks”.He also gave a closer estimate of the robot’s price tag: Once produced "at scale," Optimus should cost somewhere between $20,000 and $30,000. Musk had previously said the robot’s price would be about half that of a car. 
Staying true to his sci-fi vision, the Tesla CEO referred to Optimus as a cross between R2D2 and C-3PO, the famous droids from the Star Wars film series.
Ever since the first generation of the Optimus was revealed in 2022, Tesla has emphasized the continuity between its cars and the robot. “Everything that we’ve developed for our cars -- the battery power’s electronics, the advanced motor’s gearboxes, the software, the AI inference computer -- it all actually applies to a humanoid robot,” Musk said at the event. “A robot with arms and legs, instead of a robot with wheels.”
Tesla would not be the first to offer a domestic robot on the market. Hyundai-owned Boston Dynamics has already commercialized a home service-type robot called Spot with a hefty price tag of $74,500. BMW and Open AI are backing robots made by Figure, a California-based company. Meanwhile, Nvidia is developing Project GR00T to also deliver humanoid robots.Earlier this year, Goldman Sachs forecast that the annual global market for humanoid robots could reach $38 billion by 2035, with robot shipments of 1.4 million units both for industrial and consumer applications. It also said that robots could become more affordable as their manufacturing cost has been decreasing more than expected -- leading to faster commercialization.

Read more
GM launches PowerBank, a battery that could rival Tesla’s PowerWall
gm launches powerbank a battery that could rival teslas powerwall energy home system bundle

Competition to provide the best energy savings to EV owners is heating up between auto makers.General Motor’s unit GM Energy has just released PowerBank, a stationary energy storage battery pack that gives electric vehicles (EV) owners the ability to store and transfer energy from the electric grid, and allows integration with home solar power equipment.The PowerBank, which comes in 10.6kWh and 17.7kWh battery capacity variants, can power up a home when there is an outage or help offset higher electricity rates during peak demand, GM said. In addition, customers can also use PowerBank to store and use solar energy, supplement the charging of EVs and provide power to a home without an EV being present.GM says that combining two of its 17.7kWh PowerBanks can provide enough energy to power the average American home for up to 20 hours.The PowerBank can be bought as part of two bundles: the GM Energy Storage bundle at $10,999, or the GM Energy Home System bundle at $12,700. The latter includes a bi-directional EV charger that can provide up to 19.2kWh of power. By comparison, Tesla’s energy storage system, PowerWall 3, can store 13.5kWh of energy and has a price tag of $9,300.According to GM Vice President Wade Sheffer, one key advantage of the PowerBank it its “modularity,” which allows for easy integration with existing technology.GM announced in August that it would provide vehicle-to-home (V2H) technology on all its model year 2026 models. It will now also offer vehicle-to-grid (V2G) technology, which can provide additional energy and financial savings.
Energy savings coming from the integration of electric vehicles, solar-powered homes, and energy grids are increasingly at the center of EV manufacturers' offerings.
Nissan, BMW, Ford, and Honda have grouped together to offer the ChargeScape V2G software, which connects EVs to utilities and the power grid. EV owners can receive financial incentives to pause charging during peak demand or sell energy back to the grid.While Tesla has so far backed off from embracing V2G technology, CEO Elon Musk has hinted that V2G tech could be introduced for Tesla vehicles in 2025.

Read more